Hvor er kildene til denne artikkelen? På måten forfatteren skriver virker det som om det er en masse gjetninger og personlige meninger, som ikke er underbygget av noe seriøs forskning. Skal denne artikkelen tas seriøst må det hvertfall komme frem hvor alle påstandene kommer fra. Virker nesten som det er fritt frem for hvem som helst skrive fantasihistorier om ymse kosttilskudd og få det lagt ut på treningsforum.
Du kan begynne med disse:
Zhang J et al. Human skeletal muscle PPAR expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity. Am J Physiol Endocrinol Metab 286: E168-E175, 2004.
Gibbons G et al. The functional efficiency of lipogenic and cholesterogenic gene expression in normal mice and in mice lacking the peroxisomal proliferator-activated receptor-alpha (PPAR-alpha). Adv Enzyme Regul. 2002;42:227-47.
Erol A. PPARalpha activators may be good candidates as antiaging agents. Med Hypotheses. 2005 Jan;65(1):35-8.
Okamoto H et al. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol. 2005 May-Jun;23(3):323-30.
Ashakumary L et al. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999 Oct;48(10):1303-13.
Takashi et. al. Sesamin, a sesame lignan, as a potent serum-lipid lowering component. JARQ 37(3), 151-158.
Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev. 2004 Sep;62(9):333-9.
Gibbons G. Old fat, make way for new fat. 2005, Nature Medicine vol. 11: 722-723.
Ide T et al. Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta. 2001 Nov 30;1534(1):1-13.
Poynter M et al. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998 Dec 4;273(49):32833-41.
Pineda Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol. 1999 Apr;10(2):151-9.
Jeng K et al. Sesamin and Sesamoline: Nature’s Therapeutic Lignans. Current Enzyme Inhibition(1), 2005; 11-20.
Stannard et al. Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes? J Physiol. 2004 Feb 1;554(Pt 3):595-607. Epub 2003 Nov 7. Review.
Ziegler Q et al. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity] Diabetes Metab. 2001 Apr;27(2 Pt 2):261-70. Review. French.
Hirose N et al. Inhibition of cholesterol absorption and synthesis in rats by sesamin. Journal of Lipid Research 1991, Vol 32, 629-638.
Nakabayashi A, Kitagawa Y, Suwa Y, Akimoto K, Asami S, Shimizu S, Hirose N, Sugano M, Yamada H. alpha-Tocopherol enhances the hypocholesterolemic action of sesamin in rats. Int J Vitam Nutr Res. 1995;65(3):162-8.
Ogawa H, Sasagawa S, Murakami T, Yoshizumi H. Sesame lignans modulate cholesterol metabolism in the stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S310-2.
Ide T. Interaction of dietary fat types and sesamin on hepatic fatty acid oxidation in rats. Biochim Biophys Acta. 2004 Jun 1;1682(1-3):80-91.
Toruner F. et al. Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats. Horm Metab Res. 2004 Apr;36(4):226-30.
Kim H et al. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes. 2003 Jul;52(7):1770-8.
Muhammad S. Epidemiology of diabetes and obesity in the United States. Compend Contin Educ Dent. 2004 Mar;25(3):195-8, 200, 202;
Fry F et al. Multifunctional redox catalysts as selective enhancers of oxidative stress.
Org Biomol Chem. 2005 Jul 21;3(14):2579-87. Epub 2005 Jun 9.
McCord J et al. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother. 2005 May;59(4):139-42. Epub 2005 Mar 22.
D. Nakano, M. Takaoka, Y. Kiso and Y. Matsumura. Antihypertensive Effect of Sesamin Vascular Disease Prevention, Vol. 1, No. 3, 2004; 233-241
Ohto U et al. Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor. J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):105-8. Epub 2003 Nov 28.
Matsumura et al. Effects of sesamin on altered vascular reactivity in aortic rings of deoxycorticosterone acetate-salt-induced hypertensive rat. Biol Pharm Bull. 2000 Sep;23(9):1041-5.
Ikeda S. et al. Dietary sesame lignans decrease lipid peroxidation in rats fed docosahexaenoic acid. J Nutr Sci Vitaminol (Tokyo). 2003 Aug;49(4):270-6.
Parker R et al. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun. 2000 Nov 2;277(3):531-4.
Hemalatha et al. Dietary sesame oils inhibits iron-induced oxidative stress in rats [corrected] Br J Nutr. 2004 Oct;92(4):581-7. Erratum in: Br J Nutr. 2004 Dec;92(6):1017.
Ikeda T. et al. Protective effect of sesamin administration on exercise-induced lipid peroxidation. Int J Sports Med. 2003 Oct;24(7):530-4.
Akimoto K, Kitagawa Y, Akamatsu T, Hirose N, Sugano M, Shimizu S, Yamada H. Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab. 1993;37(4):218-24.
Noguchi T. et al. Effects of vitamin e and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2004 Dec;31 Suppl 2:S24-6.
Hirose N et al. Inhibition of cholesterol absorption and synthesis in rats by sesamin. Journal of Lipid Research 1991, Vol 32, 629-638.
Hirata F et al. Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis. 1996 Apr 26;122(1):135-36.
Chevali S et al. Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids. 1998 Mar;58(3):185-91.